References
- Yilmaz H, Sayar N, Yilmaz M, Tangurek B, Cakmak N, Gurkan U, Gul M, Simsek D, Bolca O. Coronary artery ectasia: clinical and angiographical evaluation. Turk Kardiyol Dern Ars. 2008;36:530–35.
- Markis JE, Joffe CD, Cohn PF, Feen DJ, Herman MV, Gorlin R. Clinical significance of coronary arterial ectasia. Am J Cardiol. 1976;37:217–22. doi:https://doi.org/10.1016/0002-9149(76)90315-5.
- Ahmad M, Mungee S. Coronary Ectasia: StatPearls Publishing, Treasure Island (FL). Coronary ectasia. 2020; PMID: 31082174.
- Zhao LP, Xu WT, Wang L, You T, Chan SP, Zhao X, Yang XJ. Serum adropin level in patients with stable coronary artery disease. Heart Lung Circ. 2015;24:975–79. doi:https://doi.org/10.1016/j.hlc.2015.03.008.
- Kumar KG, Trevaskis JL, Lam DD, Sutton GM, Koza RA, Chouljenko VN, Kousoulas KG, Rogers PM, Kesterson RA, Thearle M, et al. Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolism. Cell Metab. 2008;8:468–81. doi:https://doi.org/10.1016/j.cmet.2008.10.011.
- Lovren F, Pan Y, Quan A, Singh KK, Shukla PC, Gupta M, Al-Omran M, Teoh H, Verma S. Adropin is a novel regulator of endothelial function. Circulation. 2010;122:S185–192. doi:https://doi.org/10.1161/CIRCULATIONAHA.109.931782.
- Kelly DP. Irisin, light my fire. Science. 2012;336:42. doi:https://doi.org/10.1126/science.1221688.
- Xiong X-Q, Chen D, Sun H-J, Ding L, Wang -J-J, Chen Q, Li Y-H, Zhou Y-B, Han Y, Zhang F, et al. FNDC5 overexpression and irisin ameliorate glucose/lipid metabolic derangements and enhance lipolysis in obesity. Biochimica Et Biophysica Acta (BBA) - Mol Basis Dis. 2015;1852:1867–75. doi:https://doi.org/10.1016/j.bbadis.2015.06.017.
- Wrann CD, White JP, Salogiannnis J, Laznik-Bogoslavski D, Wu J, Ma D, Lin JD, Greenberg ME, Spiegelman BM. Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway. Cell Metab. 2013;18:649–59. doi:https://doi.org/10.1016/j.cmet.2013.09.008.
- Zhang Y, Xie C, Wang H, Foss RM, Clare M, Ev G, Li S, Katz A, Cheng H, Ding Y, et al. Irisin exerts dual effects on browning and adipogenesis of human white adipocytes. Am J Physiol-Endocrinol Metab. 2016;311:E530–E541. doi:https://doi.org/10.1152/ajpendo.00094.2016.
- Aksu T, Uygur B, Durukan Kosar M, Guray U, Arat N, Korkmaz S, Colak A. [Coronary artery ectasia: its frequency and relationship with atherosclerotic risk factors in patients undergoing cardiac catheterization]. Anadolu Kardiyoloji Dergisi: AKD = the Anatolian J Cardiol. 2011;11:280–84. doi:https://doi.org/10.5152/akd.2011.076.
- Ozturk S, Yetkin E, Waltenberger J. Molecular and cellular insights into the pathogenesis of coronary artery ectasia. Cardiovasc Pathol. 2018;35:37–47. doi:https://doi.org/10.1016/j.carpath.2018.04.005.
- Yetkin E, Waltenberger J. Novel insights into an old controversy: is coronary artery ectasia a variant of coronary atherosclerosis? Clin Res Cardiol. 2007;96:331–39. doi:https://doi.org/10.1007/s00392-007-0521-0.
- Yetkin E, Acikgoz N, Aksoy Y, Bariskaner E, Sivri N, Akturk E, Turhan H, Kosar F, Cehreli S. Decreased carotid intima-media thickness in patients with coronary artery ectasia compared with patients with coronary artery disease. Coron Artery Dis. 2005;16:495–98. doi:https://doi.org/10.1097/00019501-200512000-00007.
- Yildirim N, Tekin IO, Arasli M, Aydin M. Further increase in the expression of activation markers on monocyte-derived dendritic cells in coronary artery disease patients with ectasia compared to patients with coronary artery disease alone. Mediators Inflamm. 2010;2010:748919. doi:https://doi.org/10.1155/2010/748919.
- Turhan H, Erbay AR, Yasar AS, Balci M, Bicer A, Yetkin E. Comparison of C-reactive protein levels in patients with coronary artery ectasia versus patients with obstructive coronary artery disease. Am J Cardiol. 2004;94:1303–06. doi:https://doi.org/10.1016/j.amjcard.2004.07.120.
- Ozkan B, Orscelik O, Yildirim Yaroglu H, Balci S, Ozcan MK, Celik A, Ozcan IT. Association between serum adropin levels and isolated coronary artery ectasia in patients with stable angina pectoris. Anatol J Cardiol. 2019;22:250–55. doi:https://doi.org/10.14744/AnatolJCardiol.2019.90349.
- Sezen Y, Bas M, Polat M, Yildiz A, Buyukhatipoglu H, Kucukdurmaz Z, Kaya Z, Demirbag R. The relationship between oxidative stress and coronary artery ectasia. Cardiol J. 2010;17:488–94.
- Altiparmak IH, Kaya Z, Sezen H, Aydin MS, Demirbag R, Aksoy N. The relation of serum paraoxonase-1 activity with isolated coronary artery ectasia: an observational study. Anadolu Kardiyoloji Dergisi: AKD = the Anatolian J Cardiol. 2012;12:307–12. doi:https://doi.org/10.5152/akd.2012.094.
- Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Boström EA, Choi JH, Long JZ, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481:463–68. doi:https://doi.org/10.1038/nature10777.
- Huh JY, Panagiotou G, Mougios V, Brinkoetter M, Vamvini MT, Schneider BE, Mantzoros CS. FNDC5 and irisin in humans: i. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism. 2012;61:1725–38. doi:https://doi.org/10.1016/j.metabol.2012.09.002.
- Aronis KN, Moreno M, Polyzos SA, Moreno-Navarrete JM, Ricart W, Delgado E, de La Hera J, Sahin-Efe A, Chamberland JP, Berman R, et al. Circulating irisin levels and coronary heart disease: association with future acute coronary syndrome and major adverse cardiovascular events. Int J Obes. 2015;39:156–61. doi:https://doi.org/10.1038/ijo.2014.101.
- Yin C, Hu W, Wang M, Lv W, Jia T, Xiao Y. Irisin as a mediator between obesity and vascular inflammation in Chinese children and adolescents. Nutr Metab Cardiovasc Dise. 2020;30:320–29. doi:https://doi.org/10.1016/j.numecd.2019.09.025.
- Lu J, Xiang G, Liu M, Mei W, Xiang L, Dong J. Irisin protects against endothelial injury and ameliorates atherosclerosis in apolipoprotein E-Null diabetic mice. Atherosclerosis. 2015;243:438–48. doi:https://doi.org/10.1016/j.atherosclerosis.2015.10.020.
- Petersen TN, Brunak S, Von Heijne G, SignalP NH. 4.0: discriminating signal peptides from transmembrane regions. Nat Methods. 2011;8:785–86. doi:https://doi.org/10.1038/nmeth.1701.
- Wu L, Fang J, Chen L, Zhao Z, Luo Y, Lin C, Fan L. Low serum adropin is associated with coronary atherosclerosis in type 2 diabetic and non-diabetic patients. Clin Chem Lab Med. 2014;52:751–58. doi:https://doi.org/10.1515/cclm-2013-0844.
- Yu HY, Zhao P, Wu MC, Liu J, Yin W. Serum adropin levels are decreased in patients with acute myocardial infarction. Regul Pept. 2014;190-191:46–49. doi:https://doi.org/10.1016/j.regpep.2014.04.001.
- Demircelik B, Cakmak M, Nazli Y, Gurel OM, Akkaya N, Cetin M, Cetin Z, Selcoki Y, Kurtul A, Eryonucu B. Adropin: a new marker for predicting late saphenous vein graft disease after coronary artery bypass grafting. Clin Invest Med. 2014;37:E338–344. doi:https://doi.org/10.25011/cim.v37i5.22014.